XNAS
FTLF
Market cap104mUSD
Jul 09, Last price
11.10USD
1D
2.21%
1Q
15.38%
Jan 2017
9,247.37%
IPO
186.45%
Name
FitLife Brands Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
FitLife Brands, Inc. supplies dietary supplements to health-conscious individuals across the United States and globally. Their extensive product line caters to various needs, encompassing weight management, overall well-being, and athletic performance. This includes specialized formulations designed for professional muscle development, performance-enhancing supplements for fitness enthusiasts, and offerings for men's health, alongside general diet, health, sports nutrition items, energy boosters, and meal replacement options. The company markets its diverse portfolio under well-known brand names such as NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize. These products are distributed through a multi-channel approach, including company-franchised stores, a variety of retail outlets (specialty and mass market), and e-commerce platforms. Established in 2005, the company was previously known as Bond Laboratories, Inc., adopting the FitLife Brands, Inc. name in September 2013, and maintains its headquarters in Omaha, Nebraska.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||